JOST Werke (JST) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Achieved strong profitable growth in 2025, driven by the successful and efficient integration of Hyva, organic gains, and resilience from diversified industry and geographic exposure, despite challenging global markets and volatility.
Consolidated Hyva from February 2025, capturing initial synergies ahead of plan and divesting the non-core Cranes business by year-end.
Gained market share through new customer projects, leveraging a local-for-local approach and global strength.
Set new CO2 reduction targets, aiming for a further 50% reduction per production hour by 2035 compared to 2025.
Robust order intake and visible recovery across all business lines and regions in Q1 2026.
Financial highlights
Sales from continuing operations rose 44% to approximately EUR 1.5 billion in 2025, including EUR 468.0 million from Hyva, with 2% organic growth.
Adjusted EBIT from continuing operations increased by 29% to EUR 145 million; margin reached 9.5%.
Free cash flow grew 6% to a record EUR 126 million.
Adjusted net income from continuing operations up 12% to EUR 84 million; adjusted EPS up 11% to EUR 5.52.
Dividend payout increased to EUR 1.50 per share, 30% of adjusted net income.
Outlook and guidance
2026 guidance assumes single-digit sales growth, mid to high single-digit Adjusted EBIT growth, and margin improvement, supported by further Hyva synergies.
CapEx expected at 2.8% of sales; working capital projected between 17.5%-18.5% of sales.
Guidance does not factor in major long-term impacts from the Iran conflict; upside possible if U.S. tariffs ease or EPA 2027 regulations prompt pre-buying.
Hyva PMI to conclude in 2026, with remaining synergies targeted by Q4 2026.
Robust order intake and visible recovery across all business lines and regions in Q1 2026.
Latest events from JOST Werke
- Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation5 Mar 2026 - Margins and cash flow improved despite sales decline; 2024 guidance confirmed.JST
Q2 20242 Feb 2026 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update22 Jan 2026 - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 202421 Jan 2026 - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement20 Jan 2026 - Despite sales declines, strong cash flow and key acquisitions support future growth.JST
Q3 202414 Jan 2026 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 202417 Dec 2025 - Q2 2025 sales up 31% on Hyva deal, with 2025 outlook reaffirmed despite margin pressure.JST
Q2 202523 Nov 2025 - Hyva acquisition drove 25% Q1 sales growth, with strong cash flow and higher leverage.JST
Q1 202521 Nov 2025